CN1241662A - 纳米银长效广谱抗菌功能性织物及其制造方法 - Google Patents
纳米银长效广谱抗菌功能性织物及其制造方法 Download PDFInfo
- Publication number
- CN1241662A CN1241662A CN 99111155 CN99111155A CN1241662A CN 1241662 A CN1241662 A CN 1241662A CN 99111155 CN99111155 CN 99111155 CN 99111155 A CN99111155 A CN 99111155A CN 1241662 A CN1241662 A CN 1241662A
- Authority
- CN
- China
- Prior art keywords
- fabric
- silver
- long
- nano
- hno
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000004744 fabric Substances 0.000 title claims abstract description 98
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 title claims abstract description 43
- 229910052709 silver Inorganic materials 0.000 title claims abstract description 21
- 239000004332 silver Substances 0.000 title claims abstract description 21
- 238000000034 method Methods 0.000 title claims description 8
- 238000001228 spectrum Methods 0.000 title description 3
- 230000002421 anti-septic effect Effects 0.000 title 1
- 239000000835 fiber Substances 0.000 claims abstract description 6
- NDVLTYZPCACLMA-UHFFFAOYSA-N silver oxide Chemical compound [O-2].[Ag+].[Ag+] NDVLTYZPCACLMA-UHFFFAOYSA-N 0.000 claims abstract description 6
- 208000015181 infectious disease Diseases 0.000 claims abstract description 3
- 229910001923 silver oxide Inorganic materials 0.000 claims abstract description 3
- 206010040872 skin infection Diseases 0.000 claims abstract description 3
- 239000002344 surface layer Substances 0.000 claims abstract description 3
- 230000000844 anti-bacterial effect Effects 0.000 claims description 40
- 229910017604 nitric acid Inorganic materials 0.000 claims description 23
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 23
- SQGYOTSLMSWVJD-UHFFFAOYSA-N silver(I) nitrate Inorganic materials [Ag+].[O-]N(=O)=O SQGYOTSLMSWVJD-UHFFFAOYSA-N 0.000 claims description 16
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 claims description 14
- 239000002245 particle Substances 0.000 claims description 13
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims description 12
- 239000002904 solvent Substances 0.000 claims description 8
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 6
- 239000003795 chemical substances by application Substances 0.000 claims description 6
- 229910052742 iron Inorganic materials 0.000 claims description 6
- 239000007800 oxidant agent Substances 0.000 claims description 6
- 230000001590 oxidative effect Effects 0.000 claims description 6
- NUJOXMJBOLGQSY-UHFFFAOYSA-N manganese dioxide Chemical compound O=[Mn]=O NUJOXMJBOLGQSY-UHFFFAOYSA-N 0.000 claims description 4
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 claims description 3
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims description 3
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 claims description 3
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 3
- 239000000460 chlorine Substances 0.000 claims description 3
- 229910052801 chlorine Inorganic materials 0.000 claims description 3
- 206010017533 Fungal infection Diseases 0.000 claims description 2
- 208000031888 Mycoses Diseases 0.000 claims description 2
- 208000002847 Surgical Wound Diseases 0.000 claims description 2
- 206010053615 Thermal burn Diseases 0.000 claims description 2
- 208000014674 injury Diseases 0.000 claims description 2
- 239000012286 potassium permanganate Substances 0.000 claims description 2
- 230000008733 trauma Effects 0.000 claims description 2
- 239000010946 fine silver Substances 0.000 claims 1
- 241000233866 Fungi Species 0.000 abstract description 3
- 229910052751 metal Inorganic materials 0.000 abstract 1
- 239000002184 metal Substances 0.000 abstract 1
- 230000000472 traumatic effect Effects 0.000 abstract 1
- 230000028327 secretion Effects 0.000 description 25
- 229920000742 Cotton Polymers 0.000 description 17
- 239000000243 solution Substances 0.000 description 16
- 238000012360 testing method Methods 0.000 description 16
- 238000005406 washing Methods 0.000 description 13
- 230000003385 bacteriostatic effect Effects 0.000 description 12
- 230000000694 effects Effects 0.000 description 11
- 241000894006 Bacteria Species 0.000 description 8
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 8
- 239000003814 drug Substances 0.000 description 8
- 238000010409 ironing Methods 0.000 description 8
- 229910002651 NO3 Inorganic materials 0.000 description 7
- 229940079593 drug Drugs 0.000 description 7
- 238000000338 in vitro Methods 0.000 description 7
- 241000191967 Staphylococcus aureus Species 0.000 description 6
- 238000004519 manufacturing process Methods 0.000 description 6
- ULGZDMOVFRHVEP-RWJQBGPGSA-N Erythromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 ULGZDMOVFRHVEP-RWJQBGPGSA-N 0.000 description 4
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 4
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 4
- 206010041925 Staphylococcal infections Diseases 0.000 description 4
- 239000003242 anti bacterial agent Substances 0.000 description 4
- 244000052616 bacterial pathogen Species 0.000 description 4
- 239000008103 glucose Substances 0.000 description 4
- 230000005764 inhibitory process Effects 0.000 description 4
- 208000015688 methicillin-resistant staphylococcus aureus infectious disease Diseases 0.000 description 4
- 238000002156 mixing Methods 0.000 description 4
- 238000005303 weighing Methods 0.000 description 4
- 241000193830 Bacillus <bacterium> Species 0.000 description 3
- 241000222122 Candida albicans Species 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- CEAZRRDELHUEMR-URQXQFDESA-N Gentamicin Chemical compound O1[C@H](C(C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N CEAZRRDELHUEMR-URQXQFDESA-N 0.000 description 3
- 241000122973 Stenotrophomonas maltophilia Species 0.000 description 3
- 230000001580 bacterial effect Effects 0.000 description 3
- 229940095731 candida albicans Drugs 0.000 description 3
- 239000010949 copper Substances 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 230000007246 mechanism Effects 0.000 description 3
- 230000035945 sensitivity Effects 0.000 description 3
- 238000002791 soaking Methods 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- 239000004753 textile Substances 0.000 description 3
- 241000607534 Aeromonas Species 0.000 description 2
- 244000063299 Bacillus subtilis Species 0.000 description 2
- 235000014469 Bacillus subtilis Nutrition 0.000 description 2
- 241000588923 Citrobacter Species 0.000 description 2
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 2
- 241000588724 Escherichia coli Species 0.000 description 2
- 229930182566 Gentamicin Natural products 0.000 description 2
- SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical compound C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 description 2
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 2
- FOIXSVOLVBLSDH-UHFFFAOYSA-N Silver ion Chemical compound [Ag+] FOIXSVOLVBLSDH-UHFFFAOYSA-N 0.000 description 2
- 241000191963 Staphylococcus epidermidis Species 0.000 description 2
- 241000194017 Streptococcus Species 0.000 description 2
- 241000607265 Vibrio vulnificus Species 0.000 description 2
- 241000222126 [Candida] glabrata Species 0.000 description 2
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 2
- 229960000723 ampicillin Drugs 0.000 description 2
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 2
- 229940124350 antibacterial drug Drugs 0.000 description 2
- 208000032343 candida glabrata infection Diseases 0.000 description 2
- MYSWGUAQZAJSOK-UHFFFAOYSA-N ciprofloxacin Chemical compound C12=CC(N3CCNCC3)=C(F)C=C2C(=O)C(C(=O)O)=CN1C1CC1 MYSWGUAQZAJSOK-UHFFFAOYSA-N 0.000 description 2
- 239000002131 composite material Substances 0.000 description 2
- 229910052802 copper Inorganic materials 0.000 description 2
- 239000002781 deodorant agent Substances 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 229960003276 erythromycin Drugs 0.000 description 2
- 229960002518 gentamicin Drugs 0.000 description 2
- 208000004396 mastitis Diseases 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 241000588626 Acinetobacter baumannii Species 0.000 description 1
- 229920002972 Acrylic fiber Polymers 0.000 description 1
- 241000607528 Aeromonas hydrophila Species 0.000 description 1
- 241000588813 Alcaligenes faecalis Species 0.000 description 1
- 241000193755 Bacillus cereus Species 0.000 description 1
- 108010077805 Bacterial Proteins Proteins 0.000 description 1
- 241000700198 Cavia Species 0.000 description 1
- KEJCWVGMRLCZQQ-YJBYXUATSA-N Cefuroxime axetil Chemical compound N([C@@H]1C(N2C(=C(COC(N)=O)CS[C@@H]21)C(=O)OC(C)OC(C)=O)=O)C(=O)\C(=N/OC)C1=CC=CO1 KEJCWVGMRLCZQQ-YJBYXUATSA-N 0.000 description 1
- 241000193468 Clostridium perfringens Species 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- 241000588914 Enterobacter Species 0.000 description 1
- 241000588697 Enterobacter cloacae Species 0.000 description 1
- 241001360526 Escherichia coli ATCC 25922 Species 0.000 description 1
- 241000192125 Firmicutes Species 0.000 description 1
- 241000235503 Glomus Species 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 241000588915 Klebsiella aerogenes Species 0.000 description 1
- 241000588747 Klebsiella pneumoniae Species 0.000 description 1
- 241000780272 Mammilla Species 0.000 description 1
- 241000588652 Neisseria gonorrhoeae Species 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- AEKNYBWUEYNWMJ-QWOOXDRHSA-N Pramiconazole Chemical compound O=C1N(C(C)C)CCN1C1=CC=C(N2CCN(CC2)C=2C=CC(OC[C@@H]3O[C@](CN4N=CN=C4)(CO3)C=3C(=CC(F)=CC=3)F)=CC=2)C=C1 AEKNYBWUEYNWMJ-QWOOXDRHSA-N 0.000 description 1
- 241000588769 Proteus <enterobacteria> Species 0.000 description 1
- 241000588770 Proteus mirabilis Species 0.000 description 1
- 241000588767 Proteus vulgaris Species 0.000 description 1
- 241000589614 Pseudomonas stutzeri Species 0.000 description 1
- 241000607142 Salmonella Species 0.000 description 1
- 241000531795 Salmonella enterica subsp. enterica serovar Paratyphi A Species 0.000 description 1
- 241000607715 Serratia marcescens Species 0.000 description 1
- 206010040943 Skin Ulcer Diseases 0.000 description 1
- 241000191940 Staphylococcus Species 0.000 description 1
- 241000193996 Streptococcus pyogenes Species 0.000 description 1
- UCKMPCXJQFINFW-UHFFFAOYSA-N Sulphide Chemical compound [S-2] UCKMPCXJQFINFW-UHFFFAOYSA-N 0.000 description 1
- 241000223238 Trichophyton Species 0.000 description 1
- 230000007059 acute toxicity Effects 0.000 description 1
- 231100000403 acute toxicity Toxicity 0.000 description 1
- 229940005347 alcaligenes faecalis Drugs 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000000172 allergic effect Effects 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 229960001139 cefazolin Drugs 0.000 description 1
- MLYYVTUWGNIJIB-BXKDBHETSA-N cefazolin Chemical compound S1C(C)=NN=C1SCC1=C(C(O)=O)N2C(=O)[C@@H](NC(=O)CN3N=NN=C3)[C@H]2SC1 MLYYVTUWGNIJIB-BXKDBHETSA-N 0.000 description 1
- 229960000484 ceftazidime Drugs 0.000 description 1
- NMVPEQXCMGEDNH-TZVUEUGBSA-N ceftazidime pentahydrate Chemical compound O.O.O.O.O.S([C@@H]1[C@@H](C(N1C=1C([O-])=O)=O)NC(=O)\C(=N/OC(C)(C)C(O)=O)C=2N=C(N)SC=2)CC=1C[N+]1=CC=CC=C1 NMVPEQXCMGEDNH-TZVUEUGBSA-N 0.000 description 1
- 229960001668 cefuroxime Drugs 0.000 description 1
- JFPVXVDWJQMJEE-IZRZKJBUSA-N cefuroxime Chemical compound N([C@@H]1C(N2C(=C(COC(N)=O)CS[C@@H]21)C(O)=O)=O)C(=O)\C(=N/OC)C1=CC=CO1 JFPVXVDWJQMJEE-IZRZKJBUSA-N 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 229960003405 ciprofloxacin Drugs 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 239000007382 columbia agar Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 230000006806 disease prevention Effects 0.000 description 1
- 229940092559 enterobacter aerogenes Drugs 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 238000002682 general surgery Methods 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 230000002949 hemolytic effect Effects 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 239000002085 irritant Substances 0.000 description 1
- 231100000021 irritant Toxicity 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 230000005923 long-lasting effect Effects 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 230000000399 orthopedic effect Effects 0.000 description 1
- UWYHMGVUTGAWSP-JKIFEVAISA-N oxacillin Chemical compound N([C@@H]1C(N2[C@H](C(C)(C)S[C@@H]21)C(O)=O)=O)C(=O)C1=C(C)ON=C1C1=CC=CC=C1 UWYHMGVUTGAWSP-JKIFEVAISA-N 0.000 description 1
- 229960001019 oxacillin Drugs 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 229920002239 polyacrylonitrile Polymers 0.000 description 1
- 230000002980 postoperative effect Effects 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 229940007042 proteus vulgaris Drugs 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 238000005201 scrubbing Methods 0.000 description 1
- 231100000019 skin ulcer Toxicity 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 230000007480 spreading Effects 0.000 description 1
- 238000003892 spreading Methods 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 238000010200 validation analysis Methods 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 238000009941 weaving Methods 0.000 description 1
- 238000009736 wetting Methods 0.000 description 1
Abstract
Description
菌名来源 | LBDF抗菌织物与对照组抑菌置径(mm) 抗菌药物MIC法药敏结果 |
洗涤 洗涤 阴性 苯唑 氨苄 头孢 头孢 头孢 庆大 环丙来洗涤 红霉素50次 100次 对照 西林 西林 唑啉 呋肟 他啶 霉素 沙星 | |
金黄色葡萄球菌 ATCC25923大肠埃希菌 ATCC25922铜绿假单胞菌 ATCC27853产气荚膜梭菌 CMCC(B)64606金黄色葡萄球菌(MRSA)分泌物表皮葡萄球菌(MRSE) 分泌物化脓性链球菌 分泌物淋病奈瑟菌 分泌物大肠埃希菌 分泌物阴沟肠杆菌 分泌物产气肠杆菌 分泌物铜绿假单胞菌 分泌物嗜麦芽窄食单胞菌 分泌物鲍曼不动杆菌 分泌物肺炎克雷伯菌 分泌物 | 18 15 15 7 24 S S S S S S S13 13 12 7 10 S S S S S S12 12 12 7 6 S S S1017 15 15 7 6 R R R R R R R18 15 16 7 6 R R R R R R R9 8 8 7 6 S S S S S S S10 10 10 7 31 S S S S S S17 14 14 7 6 R R R R R R9 8 8 7 11 R R R R R R14 12 13 7 6 R R R R R R15 15 15 7 6 R R R R R R14 13 14 7 6 R R R S R S13 12 12 7 19 R R R S S S15 14 14 7 6 R R R S R S |
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB991111559A CN1161511C (zh) | 1999-07-27 | 1999-07-27 | 纳米银长效广谱抗菌功能性织物及其制造方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB991111559A CN1161511C (zh) | 1999-07-27 | 1999-07-27 | 纳米银长效广谱抗菌功能性织物及其制造方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1241662A true CN1241662A (zh) | 2000-01-19 |
CN1161511C CN1161511C (zh) | 2004-08-11 |
Family
ID=5274915
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB991111559A Expired - Lifetime CN1161511C (zh) | 1999-07-27 | 1999-07-27 | 纳米银长效广谱抗菌功能性织物及其制造方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1161511C (zh) |
Cited By (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002018699A1 (fr) * | 2000-09-01 | 2002-03-07 | Shanghai Lange Scientific Technology Co., Ltd. | Grain antimoisissure, antimicrobien, a large spectre et a action prolongee, a argent nanometrique et procedes de production associes |
WO2002090025A1 (fr) * | 2001-04-20 | 2002-11-14 | Shenzhen Tsinghua Yuanxing Nano-Material Co., Ltd. | Procede pour preparer une micropoudre contenant de l'argent nanometrique anti-agglomeration, micropoudre produite par ce procede et son application |
WO2003046273A1 (fr) * | 2001-06-22 | 2003-06-05 | Hongjun Zhu | Textiles antibacteriens contenant de l'argent nanometrique non agglomerant fixe et leurs procedes de production |
US6692773B2 (en) | 2000-07-27 | 2004-02-17 | Nucryst Pharmaceuticals Corp. | Treatment of hyperproliferative skin disorders and diseases |
US6719987B2 (en) | 2000-04-17 | 2004-04-13 | Nucryst Pharmaceuticals Corp. | Antimicrobial bioabsorbable materials |
US6723350B2 (en) | 2001-04-23 | 2004-04-20 | Nucryst Pharmaceuticals Corp. | Lubricious coatings for substrates |
US6989157B2 (en) | 2000-07-27 | 2006-01-24 | Nucryst Pharmaceuticals Corp. | Dry powders of metal-containing compounds |
US7001617B2 (en) | 2001-04-23 | 2006-02-21 | Nueryst Pharmaceuticals Corp. | Method of induction of apoptosis and inhibition of matrix metalloproteinases using antimicrobial metals |
US7008647B2 (en) | 2001-04-23 | 2006-03-07 | Nucryst Pharmaceuticals Corp. | Treatment of acne |
WO2006042463A1 (fr) * | 2004-10-18 | 2006-04-27 | The Hong Kong Polytechnic University | Agent de finition textile et procedes de fabrication et d'application de celui-ci |
US7048771B2 (en) * | 2001-10-22 | 2006-05-23 | University Of California | Dyeing textiles using nanoparticles |
US7137968B1 (en) | 2000-03-13 | 2006-11-21 | Nucryst Pharmaceuticals Corp. | Transcutaneous medical device dressings and method of use |
US7201925B2 (en) | 2002-04-23 | 2007-04-10 | Nueryst Pharmaceuticals Corp. | Treatment of ungual and subungual diseases |
US7255881B2 (en) | 2000-07-27 | 2007-08-14 | Nucryst Pharmaceuticals Corp. | Metal-containing materials |
CN100334292C (zh) * | 2001-01-20 | 2007-08-29 | 南京希科纳米医药技术有限公司 | 一种纳米银抗菌纱线的制备方法 |
US7427416B2 (en) | 2000-07-27 | 2008-09-23 | Nucryst Pharmaceuticals Corp. | Methods of treating conditions using metal-containing materials |
US7470437B2 (en) | 2000-07-27 | 2008-12-30 | Nucryst Pharmaceuticals Corp. | Methods of treating conditions with a metal-containing material |
CN100460590C (zh) * | 2002-03-27 | 2009-02-11 | 骏安科技投资有限公司 | 具有纳米银粒子的抗微生物纱线及其生产方法 |
US7745509B2 (en) | 2003-12-05 | 2010-06-29 | 3M Innovative Properties Company | Polymer compositions with bioactive agent, medical articles, and methods |
CN102400306A (zh) * | 2010-09-14 | 2012-04-04 | 龚森淼 | 超微粒氧化银长效广谱抗菌织物及其制造方法 |
US8865227B2 (en) | 2007-12-20 | 2014-10-21 | Smith & Nephew (Overseas) Limited | Metal carbonate particles and methods of making thereof |
-
1999
- 1999-07-27 CN CNB991111559A patent/CN1161511C/zh not_active Expired - Lifetime
Cited By (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7137968B1 (en) | 2000-03-13 | 2006-11-21 | Nucryst Pharmaceuticals Corp. | Transcutaneous medical device dressings and method of use |
US6719987B2 (en) | 2000-04-17 | 2004-04-13 | Nucryst Pharmaceuticals Corp. | Antimicrobial bioabsorbable materials |
US7470437B2 (en) | 2000-07-27 | 2008-12-30 | Nucryst Pharmaceuticals Corp. | Methods of treating conditions with a metal-containing material |
US6692773B2 (en) | 2000-07-27 | 2004-02-17 | Nucryst Pharmaceuticals Corp. | Treatment of hyperproliferative skin disorders and diseases |
US7427416B2 (en) | 2000-07-27 | 2008-09-23 | Nucryst Pharmaceuticals Corp. | Methods of treating conditions using metal-containing materials |
US6989157B2 (en) | 2000-07-27 | 2006-01-24 | Nucryst Pharmaceuticals Corp. | Dry powders of metal-containing compounds |
US7255881B2 (en) | 2000-07-27 | 2007-08-14 | Nucryst Pharmaceuticals Corp. | Metal-containing materials |
WO2002018699A1 (fr) * | 2000-09-01 | 2002-03-07 | Shanghai Lange Scientific Technology Co., Ltd. | Grain antimoisissure, antimicrobien, a large spectre et a action prolongee, a argent nanometrique et procedes de production associes |
CN100334292C (zh) * | 2001-01-20 | 2007-08-29 | 南京希科纳米医药技术有限公司 | 一种纳米银抗菌纱线的制备方法 |
WO2002090025A1 (fr) * | 2001-04-20 | 2002-11-14 | Shenzhen Tsinghua Yuanxing Nano-Material Co., Ltd. | Procede pour preparer une micropoudre contenant de l'argent nanometrique anti-agglomeration, micropoudre produite par ce procede et son application |
US6939568B2 (en) | 2001-04-23 | 2005-09-06 | Nucryst Pharmaceuticals Corp. | Treatment of inflammatory skin conditions |
US6989156B2 (en) | 2001-04-23 | 2006-01-24 | Nucryst Pharmaceuticals Corp. | Therapeutic treatments using the direct application of antimicrobial metal compositions |
US6723350B2 (en) | 2001-04-23 | 2004-04-20 | Nucryst Pharmaceuticals Corp. | Lubricious coatings for substrates |
US7087249B2 (en) | 2001-04-23 | 2006-08-08 | Nucryst Pharmaceuticals Corp. | Treatment of mucosal membranes |
US7008647B2 (en) | 2001-04-23 | 2006-03-07 | Nucryst Pharmaceuticals Corp. | Treatment of acne |
US7001617B2 (en) | 2001-04-23 | 2006-02-21 | Nueryst Pharmaceuticals Corp. | Method of induction of apoptosis and inhibition of matrix metalloproteinases using antimicrobial metals |
WO2003046273A1 (fr) * | 2001-06-22 | 2003-06-05 | Hongjun Zhu | Textiles antibacteriens contenant de l'argent nanometrique non agglomerant fixe et leurs procedes de production |
US7048771B2 (en) * | 2001-10-22 | 2006-05-23 | University Of California | Dyeing textiles using nanoparticles |
CN100460590C (zh) * | 2002-03-27 | 2009-02-11 | 骏安科技投资有限公司 | 具有纳米银粒子的抗微生物纱线及其生产方法 |
US7201925B2 (en) | 2002-04-23 | 2007-04-10 | Nueryst Pharmaceuticals Corp. | Treatment of ungual and subungual diseases |
US7745509B2 (en) | 2003-12-05 | 2010-06-29 | 3M Innovative Properties Company | Polymer compositions with bioactive agent, medical articles, and methods |
US8193267B2 (en) | 2003-12-05 | 2012-06-05 | 3M Innovative Properties Company | Polymer compositions with bioactive agent, medical articles, and methods |
WO2006042463A1 (fr) * | 2004-10-18 | 2006-04-27 | The Hong Kong Polytechnic University | Agent de finition textile et procedes de fabrication et d'application de celui-ci |
US8865227B2 (en) | 2007-12-20 | 2014-10-21 | Smith & Nephew (Overseas) Limited | Metal carbonate particles and methods of making thereof |
CN102400306A (zh) * | 2010-09-14 | 2012-04-04 | 龚森淼 | 超微粒氧化银长效广谱抗菌织物及其制造方法 |
CN102400306B (zh) * | 2010-09-14 | 2015-05-13 | 龚森淼 | 超微粒氧化银长效广谱抗菌织物及其制造方法 |
Also Published As
Publication number | Publication date |
---|---|
CN1161511C (zh) | 2004-08-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1241662A (zh) | 纳米银长效广谱抗菌功能性织物及其制造方法 | |
CN1147640C (zh) | 纳米银抗菌织物的制备方法 | |
US6979491B2 (en) | Antimicrobial yarn having nanosilver particles and methods for manufacturing the same | |
US9200086B2 (en) | Nanosilver coated bacterial cellulose | |
CN1306117A (zh) | 纳米银抗菌柔性材料及其制造方法和应用 | |
CN1322474A (zh) | 防集聚广谱抗菌纳米银微粉及产业化制作工艺 | |
US6379712B1 (en) | Nanosilver-containing antibacterial and antifungal granules and methods for preparing and using the same | |
US20100003296A1 (en) | Manufacturing methods and applications of antimicrobial plant fibers having silver particles | |
JP2003531315A (ja) | 院内感染と闘うための方法及びファブリック | |
CN1291667A (zh) | 纳米银抗菌布及其工业化生产工艺 | |
CN1034090C (zh) | 长效广谱抗菌织物的制造方法 | |
CN1183285C (zh) | 一种防集聚广谱抗菌纳米银纱线的产业化制作方法 | |
KR20120046714A (ko) | 은이 화학적 및/또는 물리적으로 결합된 셀룰로오스 매트릭스의 항균성 면 섬유 제조방법 및 이로부터 얻어진 항균성 면 섬유 | |
RU2408755C1 (ru) | Состав для антисептической обработки тканых материалов | |
US20030159200A1 (en) | Antimicrobial fabrics through surface modification | |
CN1348032A (zh) | 纳米银抗菌纱线及其制造方法 | |
US9924714B2 (en) | Impregnatable matrix of plant, animal or synthetic origin or mixtures of same, containing a uniformly distributed antimicrobial compound, method for impregnating said matrix with a compound, and use thereof in the production of antimicrobial elements | |
CN1480584A (zh) | 利用纳米银与活性碳纤维的结合制作抗菌材料的方法 | |
CN1156624C (zh) | 防集聚广谱抗菌纳米银针、纺织品及产业化生产工艺 | |
RU2426560C1 (ru) | Состав для антисептической обработки тканых материалов | |
CN1596991A (zh) | 一种杀菌竹纤维纱布及其制备方法和应用 | |
KR20070029955A (ko) | 반응성 항균제, 그의 제조방법 및 이로 처리된 항균 섬유 | |
CN112210993A (zh) | 一种分层涂覆有纳米银的抗菌蚕丝绵及其制备方法 | |
WO2006031229A1 (en) | Method of producing metal-containing particles | |
KR20070029956A (ko) | 반응성 항균제, 그의 제조방법 및 이로 처리된 항균 섬유 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
WD01 | Invention patent application deemed withdrawn after publication | ||
CI01 | Publication of corrected invention patent application |
Correction item: Patent affairs Correct: Recovery review procedure False: deemed to have been withdrawn Number: 15 Page: 448 Volume: 19 |
|
ERR | Gazette correction |
Free format text: CORRECT: PATENT AFFAIRS; FROM: DEEMED WITHDRAWAL TO: RESTORATION OF AUDIT PROGRAM |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C57 | Notification of unclear or unknown address | ||
DD01 | Delivery of document by public notice |
Addressee: Zhang Desheng Document name: Notification that Application Deemed not to be Proposed |
|
C57 | Notification of unclear or unknown address | ||
DD01 | Delivery of document by public notice |
Addressee: Zhang Desheng Document name: Notification that Application Deemed not to be Proposed |
|
ASS | Succession or assignment of patent right |
Owner name: CHEN WEN ADDRESS Free format text: FORMER OWNER: XIKE GROUP CO LTD, NANJING ADDRESS Effective date: 20081121 Owner name: XIKE GROUP CO LTD, NANJING ADDRESS Free format text: FORMER OWNER: JIANG JIANHUA ADDRESS Effective date: 20081121 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20081121 Address after: 18, Pioneer Park, Lishui Economic Development Zone, Jiangsu County, Nanjing Province: 211200 Patentee after: Chen Wen Address before: 18, Pioneer Park, Lishui Economic Development Zone, Jiangsu County, Nanjing Province: 211200 Patentee before: Nanjing Xike Group Co.,Ltd. Effective date of registration: 20081121 Address after: 18, Pioneer Park, Lishui Economic Development Zone, Jiangsu County, Nanjing Province: 211200 Patentee after: Nanjing Xike Group Co.,Ltd. Address before: No 79, Yunnan North Road, Jiangsu, Nanjing: 210009 Co-patentee before: Chen Qi Patentee before: Jiang Jianhua Co-patentee before: Zhu Hongjun |
|
ASS | Succession or assignment of patent right |
Owner name: CHEN WEN Free format text: FORMER OWNER: XIKE GROUP CO LTD, NANJING Effective date: 20081121 Owner name: XIKE GROUP CO LTD, NANJING Free format text: FORMER OWNER: JIANG JIANHUA Effective date: 20081121 |
|
CX01 | Expiry of patent term |
Granted publication date: 20040811 |
|
CX01 | Expiry of patent term |